{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:42:03Z","timestamp":1794271323166,"version":"4.9.0"},"reference-count":26,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Bleeding manifestations in primary immune thrombocytopenia (ITP) range from skin petechiae to life-threatening intracranial hemorrhage (ICH). However, the relation between these various bleeding manifestations and the platelet count in ITP remains poorly characterized. Using a nationwide database of patients with ITP during the years 2005 to 2014 (10 years) in Japan, we analyzed 19\u2009415 adult patients newly diagnosed with ITP, including 222 with ICH. The frequency of skin purpura was 64.8%, and this increased linearly with thrombocytopenia without a specific platelet count threshold. In contrast, mucosal bleeding (epistaxis and gingival bleeding) and organ bleeding (melena, hematuria, and ICH) increased exponentially with thrombocytopenia at a platelet count threshold of 10 to 15 \u00d7 109\/L. Age showed a much weaker correlation than platelet count with skin and mucosal bleeding. However, the incidence of organ bleeding increased exponentially above 60 years of age. Multivariate analysis showed that the presence of mucosal bleeding was a risk factor for occurrence of melena and hematuria but not for ICH. The frequency of ICH was 1.1% and risk factors for ICH were age \u226560 years (odds ratio [OR], 3.09; 95% confidence interval [CI], 2.13-4.47; P &amp;lt; .001), platelet count &amp;lt;10 \u00d7 109\/L (OR, 2.96; 95% CI, 2.11-4.15; P &amp;lt; .001), and the presence of hematuria (OR, 1.56; 95% CI, 1.04-2.35; P = .033). The relation between ICH and platelet count varied with age. This large-scale analysis of risk factors for bleeding in ITP has revealed distinct characteristics of skin, mucosal, and organ bleeding in adult patients with newly diagnosed ITP, thus indicating those who are at a high risk of severe organ bleeding.<\/jats:p>","DOI":"10.1182\/bloodadvances.2020001446","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T15:38:28Z","timestamp":1587569908000},"page":"1648-1655","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":37,"title":["Risk factors for skin, mucosal, and organ bleeding in adults with primary ITP: a nationwide study in Japan"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8173-7439","authenticated-orcid":false,"given":"Takaaki","family":"Hato","sequence":"first","affiliation":[{"name":"Department of Blood Transfusion and Cell Therapy, Ehime University Hospital, Toon, Ehime, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Shimada","sequence":"first","affiliation":[{"name":"Center for Basic Medical Research, International University of Health and Welfare, Otawara, Tochigi, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kurata","sequence":"first","affiliation":[{"name":"Shitennoji Hidenin, Habikino, Osaka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8352-6136","authenticated-orcid":false,"given":"Masataka","family":"Kuwana","sequence":"first","affiliation":[{"name":"Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingo","family":"Fujimura","sequence":"first","affiliation":[{"name":"Faculty of Nursing, Yasuda Women's University, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4814-8667","authenticated-orcid":false,"given":"Hirokazu","family":"Kashiwagi","sequence":"first","affiliation":[{"name":"Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Takafuta","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Hiroshima City Funairi Citizens Hospital, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Murata","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Tomiyama","sequence":"first","affiliation":[{"name":"Department of Blood Transfusion, Osaka University Hospital, Suita, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"key":"2020042211382341200_B1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/asheducation-2015.1.237","article-title":"Bleeding complications in immune thrombocytopenia","volume":"2015","author":"Arnold","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"2020042211382341200_B2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2141.2009.07615.x","article-title":"Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database","volume":"145","author":"Schoonen","year":"2009","journal-title":"Br J Haematol"},{"issue":"11","key":"2020042211382341200_B3","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1001\/archinte.160.11.1630","article-title":"The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts","volume":"160","author":"Cohen","year":"2000","journal-title":"Arch Intern Med"},{"issue":"2","key":"2020042211382341200_B4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bjh.12869","article-title":"Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study","volume":"166","author":"Frederiksen","year":"2014","journal-title":"Br J Haematol"},{"issue":"5","key":"2020042211382341200_B5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1067\/mpd.2002.128547","article-title":"Grading of hemorrhage in children with idiopathic thrombocytopenic purpura","volume":"141","author":"Buchanan","year":"2002","journal-title":"J Pediatr"},{"issue":"9","key":"2020042211382341200_B6","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/jth.14227","article-title":"Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults","volume":"16","author":"Piel-Julian","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"23","key":"2020042211382341200_B7","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1182\/blood-2009-04-215525","article-title":"Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases","volume":"114","author":"Psaila","year":"2009","journal-title":"Blood"},{"issue":"12","key":"2020042211382341200_B8","doi-asserted-by":"crossref","first-page":"E499","DOI":"10.1002\/ajh.24529","article-title":"Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: a study of 27 cases","volume":"91","author":"Melboucy-Belkhir","year":"2016","journal-title":"Am J Hematol"},{"issue":"13","key":"2020042211382341200_B9","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1182\/blood-2010-10-312819","article-title":"Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study","volume":"117","author":"N\u00f8rgaard","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2020042211382341200_B10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4274\/Tjh.2013.0161","article-title":"Presence of essential hypertension or diabetes mellitus is a predictor of intracranial bleeding in elderly patients: a study of 108 patients with isolated thrombocytopenia from a single reference center","volume":"32","author":"Kapoor","year":"2015","journal-title":"Turk J Haematol"},{"issue":"11","key":"2020042211382341200_B11","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00277-017-3095-6","article-title":"Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients","volume":"96","author":"Tsuda","year":"2017","journal-title":"Ann Hematol"},{"issue":"3","key":"2020042211382341200_B12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/jth.12813","article-title":"Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review","volume":"13","author":"Neunert","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2020042211382341200_B13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12185-011-0791-1","article-title":"Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review","volume":"93","author":"Kurata","year":"2011","journal-title":"Int J Hematol"},{"issue":"6","key":"2020042211382341200_B14","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1365-2141.2003.04547.x","article-title":"Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients","volume":"122","author":"Neylon","year":"2003","journal-title":"Br J Haematol"},{"issue":"1","key":"2020042211382341200_B15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00277-012-1567-2","article-title":"Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China","volume":"92","author":"Zhou","year":"2013","journal-title":"Ann Hematol"},{"issue":"4","key":"2020042211382341200_B16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ajh.2830480408","article-title":"Reliability of automated platelet counts: comparison with manual method and utility for prediction of clinical bleeding","volume":"48","author":"Lawrence","year":"1995","journal-title":"Am J Hematol"},{"issue":"1","key":"2020042211382341200_B17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V77.1.31.31","article-title":"High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura","volume":"77","author":"Cortelazzo","year":"1991","journal-title":"Blood"},{"issue":"22","key":"2020042211382341200_B18","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1182\/blood-2014-05-578336","article-title":"Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France","volume":"124","author":"Moulis","year":"2014","journal-title":"Blood"},{"key":"2020042211382341200_B19","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1053\/j.seminhematol.2013.03.009","article-title":"Individualized treatment for immune thrombocytopenia: predicting bleeding risk","volume":"50","author":"Neunert","year":"2013","journal-title":"Semin Hematol"},{"issue":"2","key":"2020042211382341200_B20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2007.06635.x","article-title":"The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP","volume":"138","author":"Page","year":"2007","journal-title":"Br J Haematol"},{"issue":"3","key":"2020042211382341200_B21","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1097\/MPH.0000000000000292","article-title":"Severe hemorrhage in Chinese children with immune thrombocytopenia","volume":"37","author":"Zhou","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"2020042211382341200_B22","first-page":"15","article-title":"Intracranial hemorrhage in patients with hematologic disorders: prevalence and predictive factors","volume":"99","author":"Owattanapanich","year":"2016","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"2020042211382341200_B23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"issue":"14","key":"2020042211382341200_B24","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2012-07-442392","article-title":"Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group","volume":"121","author":"Rodeghiero","year":"2013","journal-title":"Blood"},{"issue":"22","key":"2020042211382341200_B25","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"issue":"23","key":"2020042211382341200_B26","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia [published correction appears in Blood Adv. 2020;4(2):252]","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/8\/1648\/1724816\/advancesadv2020001446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/8\/1648\/1724816\/advancesadv2020001446.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T15:38:49Z","timestamp":1587569929000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/8\/1648\/454444\/Risk-factors-for-skin-mucosal-and-organ-bleeding"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,4,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2020001446","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]}}}